Biomarkers in Asthma (New Webinar)
Published: September 14, 2026
Join us for a FREE Webinar: December 1st, 2026 | 12 PM ET
Join us for an educational webinar exploring how advances in asthma biomarkers are transforming diagnosis, phenotyping, and treatment selection. Biomarkers are increasingly important for understanding disease activity and guiding treatment decisions. Attendees can expect to gain practical, up-to-date insights to strengthen clinical decision-making across a wide range of asthma presentations.
Target Audience
This activity is intended for allergists/immunologists, pulmonologists, primary care clinicians, nurse practitioners, physician assistants, and other healthcare professionals involved in the diagnosis, management, and coordination of care for patients with asthma and allergic conditions.
Speaker:
Rohit Katial, MD, FACAAI, FAAAAI, FACP
Dr. Katial is Professor of Medicine at National Jewish Health and the University of Colorado. He received his MD at Georgetown University School of Medicine, and conducted fellowship at Fitzsimons Army Medical Center, National Jewish Health, and Walter Reed Army Medical Center. He is the current Program Director and has been on the ABAI and ACGME. He is ABIM and the ABAI certified. He is a Fellow of the ACAAI, AAAAI, and ACP. He has published extensively and has received numerous commendations for his clinical expertise, including being named to Denver’s Top Doctors for numerous consecutive year
This Advances webinar is in partnership with the American College of Allergy, Asthma & Immunology. ACAAI offers CMEs for physicians for this webinar. If you are an ACAAI member, you can obtain CME through the member portal for this Advances webinar.
All attendees will be offered a certificate of attendance. No other continuing education credit is provided.
If you’re unable to attend the live session, registered participants will receive access to the on-demand recording and supplemental resources.
Sponsored by the American College of Allergy, Asthma & Immunology










